Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021 11 02; 37(5):109957.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Blood-Brain Barrier
Brain Neoplasms
Cell Line, Tumor
Drug Repositioning
Electronic Health Records
Energy Metabolism
ErbB Receptors
Female
Fluoxetine
Glioblastoma
Humans
Mice, Nude
Permeability
Retrospective Studies
Signal Transduction
Sphingomyelin Phosphodiesterase
Sphingomyelins
Tumor Burden
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
authors with profiles
Derek A. Wainwright
Andrey Rzhetsky